{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T10:38:16Z","timestamp":1791110296711,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2008,3,1]],"date-time":"2008-03-01T00:00:00Z","timestamp":1204329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1016\/j.cca.2007.12.001","type":"journal-article","created":{"date-parts":[[2008,1,11]],"date-time":"2008-01-11T13:05:08Z","timestamp":1200056708000},"page":"109-113","source":"Crossref","is-referenced-by-count":68,"title":["Prominent increase in plasma ganglioside GM3 is associated with clinical manifestations of type I Gaucher disease"],"prefix":"10.1016","volume":"389","author":[{"given":"Karen","family":"Ghauharali-van der Vlugt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjam","family":"Langeveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldi","family":"Poppema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijmen","family":"Kuiper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla E.M.","family":"Hollak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes M.","family":"Aerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna E.M.","family":"Groener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2007.12.001_bib1","series-title":"The metabolic basis, and molecular basis of inherited disease","first-page":"365","article-title":"Gaucher disease","author":"Beutler","year":"2001"},{"key":"10.1016\/j.cca.2007.12.001_bib2","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0925-4439(93)90090-N","article-title":"Demonstration of the existence of a second, non-lysosomal glucocerebrosidase that is not deficient in Gaucher disease","volume":"1181","author":"van Weely","year":"1993","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.cca.2007.12.001_bib3","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1074\/jbc.M610544200","article-title":"Identification of the non-lysosomal glucosylceramidase as beta-glucosidase 2","volume":"282","author":"Boot","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cca.2007.12.001_bib4","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1172\/JCI29224","article-title":"Mutation of beta-glucosidase 2 causes glycolipid storage disease, and impaired male fertility","volume":"116","author":"Yildiz","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.cca.2007.12.001_bib5","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1309\/BG5VA8JRDQH1M7HN","article-title":"Gaucher cells demonstrate a distinct macrophage phenotype, and resemble alternatively activated macrophages","volume":"122","author":"Boven","year":"2004","journal-title":"Am J Clin Pathol"},{"issue":"7","key":"10.1016\/j.cca.2007.12.001_bib6","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.bbadis.2007.04.002","article-title":"Increased plasma macrophage inflammatory protein (MIP)-1alpha, and MIP-1beta levels in type 1 Gaucher disease","volume":"1772","author":"van Breemen","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.cca.2007.12.001_bib7","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1182\/blood-2003-05-1612","article-title":"Marked elevation of the chemokine CCL18\/PARC in Gaucher disease: a novel surrogate marker for assessing therapeutic intervention","volume":"103","author":"Boot","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.cca.2007.12.001_bib8","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/0026-0495(89)90165-0","article-title":"Resting energy expenditure in Gaucher's disease type 1: effect of Gaucher's cell burden on energy requirements","volume":"38","author":"Barton","year":"1989","journal-title":"Metabolism"},{"key":"10.1016\/j.cca.2007.12.001_bib9","first-page":"2653","article-title":"Increased basal glucose production in type 1 Gaucher's disease","volume":"80","author":"Corssmit","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.cca.2007.12.001_bib10","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.metabol.2006.10.014","article-title":"Very low serum adiponectin levels in patients with type 1 Gaucher disease without overt hyperglycemia","volume":"56","author":"Langeveld","year":"2007","journal-title":"Metabolism"},{"key":"10.1016\/j.cca.2007.12.001_bib11","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1074\/jbc.M103705200","article-title":"Ganglioside GM3 participates in the pathological conditions of insulin resistance","volume":"277","author":"Tagami","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cca.2007.12.001_bib12","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1073\/pnas.0635898100","article-title":"Enhanced insulin sensitivity in mice lacking ganglioside GM3","volume":"100","author":"Yamashita","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cca.2007.12.001_bib13","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.2337\/db06-0719","article-title":"Inhibiting glycosphingolipid synthesis improves glycemic control, and insulin sensitivity in animal models of type 2 diabetes","volume":"56","author":"Zhao","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.cca.2007.12.001_bib14","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.2337\/db06-1619","article-title":"Pharmacological inhibition of glucosylceramide synthase enhances insulin sensitivity","volume":"56","author":"Aerts","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.cca.2007.12.001_bib15","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1016\/S0021-9258(18)89553-9","article-title":"The fate of glucosylceramide (glucocerebroside) in genetically impaired (lysosomal beta-glucosidase deficient) Gaucher disease diploid human fibroblasts","volume":"260","author":"Saito","year":"1985","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cca.2007.12.001_bib16","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1471-4159.1982.tb07950.x","article-title":"Accumulation of glucosylceramide, and glucosylsphingosine (psychosine) in cerebrum, and cerebellum in infantile, and juvenile Gaucher disease","volume":"39","author":"Nilsson","year":"1982","journal-title":"J Neurochem"},{"key":"10.1016\/j.cca.2007.12.001_bib17","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0005-2760(82)90272-7","article-title":"The occurrence of psychosine, and other glycolipids in spleen, and liver from the three major types of Gaucher's disease","volume":"712","author":"Nilsson","year":"1982","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.cca.2007.12.001_bib18","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00005792-199211000-00002","article-title":"Gaucher disease. Clinical, laboratory, radiologic, and genetic features of 53 patients","volume":"71","author":"Zimran","year":"1992","journal-title":"Medicine"},{"key":"10.1016\/j.cca.2007.12.001_bib19","doi-asserted-by":"crossref","first-page":"185","DOI":"10.7326\/0003-4819-90-2-185","article-title":"Accurate measurement of liver, kidney, and spleen volume, and mass by computerized axial tomography","volume":"90","author":"Heymsfield","year":"1979","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cca.2007.12.001_bib20","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1182\/blood-2005-12-5072","article-title":"Superior effects of high-dose enzyme replacement therapy in type 1 Gaucher disease on bone marrow involvement, and chitotriosidase levels: a 2-center retrospective analysis","volume":"108","author":"de Fost","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.cca.2007.12.001_bib21","doi-asserted-by":"crossref","first-page":"40911","DOI":"10.1074\/jbc.M301804200","article-title":"Transglycosidase activity of chitotriosidase: improved enzymatic assay for the human macrophage chitinase","volume":"278","author":"Aguilera","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cca.2007.12.001_bib22","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.cca.2007.02.042","article-title":"Monitoring of Gaucher patients with a novel chitotriosidase assay","volume":"381","author":"Schoonhoven","year":"2007","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cca.2007.12.001_bib23","doi-asserted-by":"crossref","first-page":"25680","DOI":"10.1074\/jbc.273.40.25680","article-title":"The human chitotriosidase gene. Nature of inherited enzyme deficiency","volume":"273","author":"Boot","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cca.2007.12.001_bib24","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1373\/clinchem.2006.079012","article-title":"HPLC for simultaneous quantification of total ceramide, glucosylceramide, and ceramide trihexoside concentrations in plasma","volume":"53","author":"Groener","year":"2007","journal-title":"Clin Chem"},{"key":"10.1016\/j.cca.2007.12.001_bib25","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0076-6879(81)72011-1","article-title":"DEAE-silica gel, and DEAE-controlled porous glass as ion exchangers for the isolation of glycolipids","volume":"72","author":"Kundu","year":"1981","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.cca.2007.12.001_bib26","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ab.2004.03.051","article-title":"Analysis of fluorescently labeled glycosphingolipid-derived oligosaccharides following ceramide glycanase digestion, and anthranilic acid labeling","volume":"331","author":"Neville","year":"2004","journal-title":"Anal Biochem"},{"key":"10.1016\/j.cca.2007.12.001_bib27","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/BF00731466","article-title":"Evaluation of the efficiency of an assay procedure for gangliosides in human serum","volume":"13","author":"Negroni","year":"1996","journal-title":"Glycoconj J"},{"key":"10.1016\/j.cca.2007.12.001_bib28","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1399-0004.1982.tb01445.x","article-title":"Increased cerebrosides concentration in plasma and erythrocytes in Gaucher disease: significant differences between Type I and Type III","volume":"22","author":"Nilsson","year":"1982","journal-title":"Clin Genet"},{"key":"10.1016\/j.cca.2007.12.001_bib29","doi-asserted-by":"crossref","first-page":"26522","DOI":"10.1074\/jbc.273.41.26522","article-title":"Generation of specific deoxynojirimycin-type inhibitors of the non-lysosomal glucosylceramidase","volume":"273","author":"Overkleeft","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.cca.2007.12.001_bib30","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1042\/bj2700815","article-title":"Recycling of glucosylceramide, and sphingosine for the biosynthesis of gangliosides, and sphingomyelin in rat liver","volume":"270","author":"Trinchera","year":"1990","journal-title":"Biochem J"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898107005839?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898107005839?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T13:21:27Z","timestamp":1630502487000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898107005839"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":30,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["S0009898107005839"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2007.12.001","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}